ARTICLE | Distillery Therapeutics
Cancer
February 5, 2019 4:04 PM UTC
Mouse studies suggest an mRNA immunotherapy based on IL-36γ, IL-23 and OX40L could help treat colorectal cancer, melanoma and other cancers, including those resistant to checkpoint inhibitors. The the...